FDA appoints oncology veteran Pazdur as new top drug regulator
TL;DR Summary
The FDA has appointed oncology expert Richard Pazdur as the new head of the Center for Drug Evaluation and Research, succeeding George Tidmarsh amid a period of leadership turmoil.
- FDA taps oncology expert Pazdur as nation’s top drug regulator The Washington Post
- FDA appoints veteran oncology chief Pazdur to lead drug center Reuters
- FDA announces agency veteran will become top drug regulator after Tidmarsh resignation The Hill
- FDA broadens search for new top drug regulator after early setbacks statnews.com
- US drug regulator promotes veteran to quell unrest in top ranks Financial Times
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
60%
73 → 29 words
Want the full story? Read the original article
Read on The Washington Post